Alendronic acid/colecalciferol explained
Type: | combo |
Component1: | Alendronic acid |
Class1: | Bisphosphonate |
Component2: | Colecalciferol |
Class2: | Vitamin |
Tradename: | Fosamax Plus D, Fosavance, Adrovance, others |
Dailymedid: | Fosamax Plus D |
Pregnancy Au: | B3 |
Routes Of Administration: | By mouth |
Atc Prefix: | M05 |
Atc Suffix: | BB03 |
Legal Ca: | Rx-only |
Legal Ca Comment: | [1] |
Legal Uk: | POM |
Legal Uk Comment: | [2] |
Legal Us: | Rx-only |
Legal Eu: | Rx-only |
Legal Status: | Rx-only |
Cas Number: | 1215291-18-1 |
Kegg: | D10841 |
Alendronic acid/colecalciferol, sold under the brand name Fosamax Plus D among others, is a medication for the treatment of osteoporosis in men or in postmenopausal women.[3] [4] [5]
Alendronic acid/colecalciferol was approved for use in the United States and in the European Union in 2005.[6] [7]
Notes and References
- Web site: Product monograph brand safety updates . . 7 July 2016 . 3 April 2024 . 29 March 2024 . https://web.archive.org/web/20240329200203/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database/label-safety-assessment-update/product-monograph-brand-safety-updates.html . live .
- Web site: Fosavance Tablets - Summary of Product Characteristics (SmPC) . (emc) . 1 March 2020 . 2 March 2020 . https://web.archive.org/web/20200302055611/https://www.medicines.org.uk/emc/product/110/smpc . live .
- Web site: Fosamax Plus D- alendronate sodium and cholecalciferol tablet . DailyMed . 16 August 2019 . 1 March 2020 . 19 December 2019 . https://web.archive.org/web/20191219012915/https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c0ec7e75-03b9-4b5b-ca8b-58cb0f65b5d9 . live .
- Web site: Adrovance EPAR . European Medicines Agency (EMA) . 26 February 2020 . 1 March 2020 . 2 March 2020 . https://web.archive.org/web/20200302055641/https://www.ema.europa.eu/en/medicines/human/EPAR/adrovance . live .
- Von Schacht E, Dambacher MA, Ringe JD, Dukas L . [Combination of alendronate plus alfacalcidol in the treatment of osteoporosis. Rationale, preclinical data and clinical evidence] . German . MMW Fortschritte der Medizin . 154 . Suppl 1 . 10–21 . April 2012 . 23427364 .
- Web site: Drug Approval Package: Fosamax Plus D (Alendronate Sodium) NDA #021762 . U.S. Food and Drug Administration (FDA) . 8 June 2006 . 1 March 2020 . 2 March 2020 . https://web.archive.org/web/20200302055610/https://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/021762s000_FosamaxTOC.cfm . live .
- Web site: Fosavance EPAR . European Medicines Agency (EMA) . 9 October 2019 . 1 March 2020 . 2 March 2020 . https://web.archive.org/web/20200302055609/https://www.ema.europa.eu/en/medicines/human/EPAR/fosavance . live .